Resources

PATH and partners issue a statement with new data showing the devastating human cost of proposed Administration cuts to foreign assistance.

From 2014 to 2016, PATH coordinated pilot introduction of the injectable contraceptive subcutaneous DMPA (DMPA-SC, brand name Sayana® Press) in Burkina Faso, Niger, Senegal, and Uganda. These materials feature guidance for monitoring DMPA-SC introductions, monitoring results, and lessons learned, which can help inform contraceptive introduction programming for DMPA-SC and other methods. For more information, visit DMPA-SC: Expanding contraceptive access and options or email FPoptions@path.org.

This document provides an overview of the global, multisectoral Coalition for Access to NCD Medicines & Products. The coalition is dedicated to increasing access to essential medicines and health products to reduce the impact of noncommunicable diseases (NCDs) such as diabetes and cardiovascular disease.

The Cryptosporidium parasite is one of the leading causes of diarrheal disease among young children. This report shares highlights from PATH’s 2nd Symposium on Innovative Therapeutics for Cryptosporidium, where experts presented about the state of work in discovery, development, and commercialization of innovative treatments.

Assessment and recommendations to increase access to oxygen and pulse oximetry in Kenya